Legacy Private Trust Co. Buys 4,648 Shares of Lam Research Corporation $LRCX

Legacy Private Trust Co. increased its stake in Lam Research Corporation (NASDAQ:LRCX) by 489.8% during the 2nd quarter, HoldingsChannel reports. The firm owned 5,597 shares of the semiconductor company’s stock after buying an additional 4,648 shares during the period. Legacy Private Trust Co.’s holdings in Lam Research were worth $2,425,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the stock. DecisionMap Wealth Management LLC bought a new position in shares of Lam Research during the 2nd quarter valued at $387,000. Physician Wealth Advisors Inc. lifted its holdings in Lam Research by 7.9% in the second quarter. Physician Wealth Advisors Inc. now owns 1,013 shares of the semiconductor company’s stock valued at $439,000 after acquiring an additional 74 shares during the period. B.O.S.S. Retirement Advisors LLC purchased a new position in Lam Research in the second quarter worth about $261,000. Gibraltar Capital Management Inc. grew its stake in shares of Lam Research by 3.6% during the 2nd quarter. Gibraltar Capital Management Inc. now owns 1,050 shares of the semiconductor company’s stock valued at $455,000 after purchasing an additional 36 shares during the period. Finally, Rydar Equities Inc. increased its position in shares of Lam Research by 33.2% during the 2nd quarter. Rydar Equities Inc. now owns 5,055 shares of the semiconductor company’s stock valued at $2,190,000 after purchasing an additional 1,259 shares during the last quarter. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. HSBC reissued a “hold” rating and issued a $333.00 price objective on shares of Lam Research in a report on Monday, July 27th. Evercore reaffirmed an “outperform” rating and set a $355.00 target price on shares of Lam Research in a report on Monday, July 20th. Mizuho lifted their price target on shares of Lam Research from $380.00 to $400.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Morgan Stanley reduced their price objective on Lam Research from $404.00 to $367.00 and set an “overweight” rating for the company in a research note on Thursday, July 30th. Finally, Citigroup reaffirmed a “buy” rating and issued a $450.00 target price (up from $315.00) on shares of Lam Research in a report on Wednesday, June 17th. One analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and a consensus target price of $358.47.

Insider Buying and Selling at Lam Research

In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of the business’s stock in a transaction on Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the transaction, the director owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the transaction, the director owned 199,205 shares of the company’s stock, valued at approximately $69,881,114. This represents a 21.48% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 80,441 shares of company stock valued at $27,614,296 in the last three months. 0.31% of the stock is currently owned by corporate insiders.

Lam Research Stock Performance

NASDAQ LRCX opened at $307.17 on Thursday. The firm has a market cap of $384.37 billion, a price-to-earnings ratio of 53.33, a price-to-earnings-growth ratio of 1.30 and a beta of 1.84. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The business has a 50-day moving average price of $339.57 and a 200-day moving average price of $285.35. Lam Research Corporation has a twelve month low of $94.11 and a twelve month high of $438.50.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.13. The company had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm’s quarterly revenue was up 30.0% on a year-over-year basis. During the same quarter last year, the company earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, equities research analysts predict that Lam Research Corporation will post 9.32 EPS for the current fiscal year.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.